Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus
NCT00406549 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2024-10-02
Summary
To establish the clinical test performance characteristics of sensitivity, specificity and predictive values for direct detection of nasal Staphylococcus aureus colonization against clinical microbiology laboratory culture methods.
Conditions
- Staphylococcus Aureus
Sponsors & Collaborators
-
3M
collaborator INDUSTRY -
Solventum US LLC
lead INDUSTRY
Principal Investigators
-
Steve Gordon, M.D. · The Cleveland Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Completion
- 2007-03-31
Countries
- United States
- France
- Germany
- Netherlands
Study Locations
More Related Trials
-
Staphylococcus Aureus Caught in Action at the Site of Infection
NCT04781569 ·Status: COMPLETED
-
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne
NCT02557568 ·Status: COMPLETED ·Phase: NA
-
BacLite Rapid MRSA Clinical Performance
NCT00541632 ·Status: TERMINATED
-
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831 ·Status: COMPLETED ·Phase: NA
-
Human Immunity Against Staphylococcus Aureus Skin Infection
NCT02262819 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery
NCT02595112 ·Status: COMPLETED ·Phase: NA
-
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
NCT00156377 ·Status: COMPLETED ·Phase: PHASE4
-
Retapamulin for Reducing MRSA Nasal Carriage
NCT01461668 ·Status: COMPLETED ·Phase: PHASE4
-
Nasal Carrying by Staphylococcus Aureus ST398 Strains in Community and Hospital Settings
NCT03869255 ·Status: UNKNOWN
-
Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment
NCT00997139 ·Status: COMPLETED ·Phase: NA
-
Staphylococcus Aureus Nasal Carriage
NCT02796690 ·Status: COMPLETED
-
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
NCT06805994 ·Status: RECRUITING ·Phase: PHASE1
-
Relationship of Staphylococcal Colonization to Infection
NCT00766259 ·Status: WITHDRAWN
-
Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Aureus
NCT05889351 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections
NCT01049438 ·Status: COMPLETED ·Phase: NA
-
S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues
NCT04666532 ·Status: UNKNOWN
-
Antimicrobial Drug Use and Resistant Staphylococcus Aureus
NCT01075451 ·Status: COMPLETED
-
Nasal Swab studyComparison of Effectiveness of Povidone-iodine Versus Saline Versus 3M Skin and Nasal Antiseptic 5% Povidone-Iodine USP Swabs for Decolonizing Intranasal MSSA/MRSA
NCT02652325 ·Status: UNKNOWN ·Phase: NA
-
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
NCT05695196 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)
NCT02284555 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus
NCT04767321 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Microbiological Characterization and Nasal Carriage Rates of Methicillin Resistant Staphylococcus Aureus (MRSA) in Vancouver Downtown Eastside
NCT00247871 ·Status: COMPLETED
-
Virulence Determinants in S Aureus Bacteremia
NCT00319826 ·Status: COMPLETED
-
Volatile Organic Compounds in Staphylococcus Aureus Patients
NCT01379053 ·Status: COMPLETED
-
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
NCT03162250 ·Status: COMPLETED ·Phase: PHASE1